The emergence and rapid spread of multidrug-resistance in human pathogenic microorganisms urgently require the development of novel therapeutic strategies for the treatment of infectious diseases. From this perspective, the antimicrobial properties of the natural plant-derived products may represent an important alternative therapeutic option to synthetic drugs. Among medicinal plants, the Cardiospermum halicacabum L. (C. halicacabum), belonging to Sapindaceae family, could be a very promising candidate for its antimicrobial activity against a wide range of microorganisms, including both Gram positive and Gram negative bacteria, as well as fungal pathogens. Although the antimicrobial properties of C. halicacabum have been intensively studied, the mechanism/s by which it exerts the inhibitory activity towards the pathogenic microbes have not yet been completely understood. This review focuses on the main antimicrobial activities displayed in vitro by the plant extract, with particular attention on our recent advances. We demonstrated that C. halicacabum is able to exert in vitro a dose-dependent fungistatic effect against Trychophyton rubrum (T. rubrum) through molecular interaction with the fungal heat shock protein (Hsp)-90 chaperone. These findings are supported by a growing body of research indicating the crucial role played by the Hsp90 in the virulence of the pathogenic microorganisms, including fungal pathogens. The possible future use of C. halicacabum for treating a wide range of infectious diseases is also discussed.

Gaziano, R., Campione, E., Iacovelli, F., Pistoia, E.s., Marino, D., Milani, M., et al. (2019). Antimicrobial properties of the medicinal plant Cardiospermum halicacabum L: New evidence and future perspectives. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 23(16), 7135-7143 [10.26355/eurrev_201908_18759].

Antimicrobial properties of the medicinal plant Cardiospermum halicacabum L: New evidence and future perspectives

Gaziano R.;Campione E.;Iacovelli F.;Pistoia E. S.;Di Francesco P.;Pica F.;Orlandi A.;Falconi M.;Aquaro S.
2019

Abstract

The emergence and rapid spread of multidrug-resistance in human pathogenic microorganisms urgently require the development of novel therapeutic strategies for the treatment of infectious diseases. From this perspective, the antimicrobial properties of the natural plant-derived products may represent an important alternative therapeutic option to synthetic drugs. Among medicinal plants, the Cardiospermum halicacabum L. (C. halicacabum), belonging to Sapindaceae family, could be a very promising candidate for its antimicrobial activity against a wide range of microorganisms, including both Gram positive and Gram negative bacteria, as well as fungal pathogens. Although the antimicrobial properties of C. halicacabum have been intensively studied, the mechanism/s by which it exerts the inhibitory activity towards the pathogenic microbes have not yet been completely understood. This review focuses on the main antimicrobial activities displayed in vitro by the plant extract, with particular attention on our recent advances. We demonstrated that C. halicacabum is able to exert in vitro a dose-dependent fungistatic effect against Trychophyton rubrum (T. rubrum) through molecular interaction with the fungal heat shock protein (Hsp)-90 chaperone. These findings are supported by a growing body of research indicating the crucial role played by the Hsp90 in the virulence of the pathogenic microorganisms, including fungal pathogens. The possible future use of C. halicacabum for treating a wide range of infectious diseases is also discussed.
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/07 - Microbiologia e Microbiologia Clinica
eng
Antifungal therapeutic strategies; Antimicrobial; C. halicacabum; Hsp90; Molecular modeling; T. rubrum
https://www.europeanreview.org/wp/wp-content/uploads/7135-7143.pdf
Gaziano, R., Campione, E., Iacovelli, F., Pistoia, E.s., Marino, D., Milani, M., et al. (2019). Antimicrobial properties of the medicinal plant Cardiospermum halicacabum L: New evidence and future perspectives. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 23(16), 7135-7143 [10.26355/eurrev_201908_18759].
Gaziano, R; Campione, E; Iacovelli, F; Pistoia, Es; Marino, D; Milani, M; Di Francesco, P; Pica, F; Bianchi, L; Orlandi, A; Marsico, S; Falconi, M; Aquaro, S
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Eur Rev Med Pharmacol Sci 2019.pdf

non disponibili

Licenza: Copyright dell'editore
Dimensione 1.42 MB
Formato Adobe PDF
1.42 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2108/223836
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact